Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Initial Beneficial Ownership · 3

CV Sciences, Inc.

CVSIOTCEQUITYCurrent

Initial Beneficial Ownership

Filed Sep 9, 2026Accepted Sep 9, 2026, 6:21 PM EDTFiling CIK 1510964Accession 0001202557-26-000004
Share

Structured filing — 3

primary_doc.xml

Open full document ↗

Filing details

Report period
2026-07-09
Issuer
CV Sciences, Inc.
Issuer CIK
0001510964
Trading symbol
CVSI

Reporting owner 1

Name
CHEEVER CHARLIE E III
Reporting owner CIK
0001202557
Relationship
10% owner

Non-derivative holdings

Non-derivative holdings · 2 reported rows
SecurityAmount ownedOwnershipNature of ownership
Common Stock, $0.0001 par value per share20,026,195D
Common Stock, $0.0001 par value per share881,700IBy Trust[F1]
Table key
D
Direct
I
Indirect

Footnotes

F1
Represents 881,700 shares of Common Stock held in Trust, for which the Reporting Person serves as trustee. The Reporting Person has voting and dispositive power over the shares held by the Trust.↩ 1

Remarks

Securities beneficially owned by the Reporting Person and the Trust at time of event (26,648,711, 10.25% on 07/09/2026).

Signature 1

Signed
Charles E. Cheever III
Date
2026-09-09

Company context

CV Sciences, Inc. (OTCQB:CVSI) is a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products. The Company's products are sold through a range of sales channels from B2B to B2C. The Company's +PlusCBD™ branded products are sold at select retail locations throughout the U.S. and are the top-selling hemp-extract brand in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. With a commitment to science, +PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. The Company also produces non-cannabinoid supplements under its +PlusHLTH™ brand, with targeted formulations to optimize health, improve performance, and increase vitality. Our Cultured Foods™ brand provides a variety of 100% plant-based food products that are distributed primarily in the EU and other select markets. Cultured Foods™ caters to individuals seeking vegan, gluten-free, or flexitarian options for a wholesome and satisfying culinary experience. In addition, the Company owns Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for

Current securities

Historical securities (1)

Recent company filings

  1. Results of Operations and Financial Condition · Regulation FD DisclosureNov 12, 2026
  2. Other EventsOct 26, 2026
  3. 4 filingSep 9, 2026
  4. 10-Q filingAug 13, 2026
  5. Results of Operations and Financial Condition · Other EventsAug 13, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.